Item 1A. Risk Factors
3K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
For a discussion of our risk factors please see the section entitled “Risk Factors” in our 2023 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The table below summarizes our repurchases of common stock during the three months ended June 30, 2024.
| Period | Total Number of Shares Purchased | Average Price Paid per Share**(1)(2)** | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs ($ in millions) | ||||||||||||||||||||||
| March 30, 2024 - April 26, 2024 | 118,798 | $ | 460.43 | 118,798 | $ | 2,391 | ||||||||||||||||||||
| April 27, 2024 - May 24, 2024 | 821,306 | NM(2) | 821,306 | 2,177 | ||||||||||||||||||||||
| May 25, 2024 - June 28, 2024 | 691,988 | $ | 437.31 | 691,988 | 1,874 | |||||||||||||||||||||
| Total | 1,632,092 | NM(2) | 1,632,092 | $ | 1,874 |
(1)Excludes commissions paid and other costs of execution, including taxes.
(2)During the first quarter of 2024, the company entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley, which was completed on May 1, 2024. Pursuant to the terms of the ASR, a total of approximately 2.2 million shares of our common stock were repurchased with an average final purchase price of of $455.73 (1.8 million shares in January 2024 and 0.4 million shares in May 2024).
Share repurchases take place from time to time, subject to market conditions and management’s discretion, in the open market or in privately negotiated transactions. The company retires its common stock upon repurchase and, in the periods presented, has not made any purchases of common stock other than in connection with these publicly announced repurchase programs.
See Note 2 to the financial statements for further information on our share repurchase programs.
-33-
NORTHROP GRUMMAN CORPORATION
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information